Hualan Biological Engineering (SZSE:002007) Accounts Payable & Accrued Expense : ¥1,206 Mil (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Accounts Payable & Accrued Expense?

Hualan Biological Engineering's quarterly accounts payable & accrued expense declined from Sep. 2024 (¥1,530 Mil) to Dec. 2024 (¥1,374 Mil) and declined from Dec. 2024 (¥1,374 Mil) to Mar. 2025 (¥1,206 Mil).

Hualan Biological Engineering's annual accounts payable & accrued expense increased from Dec. 2022 (¥1,332 Mil) to Dec. 2023 (¥1,572 Mil) but then declined from Dec. 2023 (¥1,572 Mil) to Dec. 2024 (¥1,374 Mil).

Hualan Biological Engineering Accounts Payable & Accrued Expense Historical Data

The historical data trend for Hualan Biological Engineering's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering Accounts Payable & Accrued Expense Chart

Hualan Biological Engineering Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,509.22

1,395.52

1,332.30

1,571.92

1,373.66

Hualan Biological Engineering Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,350.50	1,263.79	1,529.79	1,373.66	1,205.60

Hualan Biological Engineering Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Hualan Biological Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003

Website

http://www.hualanbio.com

Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

Executives

Chen Zheng Yue	Executives
Fan Bei	Directors, executives
Pan Ruo Wen	Executives
Xie Jun Min	Directors, executives
An Wen Qi	Executives
An Kang	Directors, executives
Ma Xiao Wei	Executives
Zhang Bao Xian	Executives
An Wen Jue	Director
Liu Jun	Executives
Wang Qi Ping	Directors, executives
Lv Cheng Yu	Securities Affairs Representative
Zhang Jin Gang	Independent director
Wang Li Ting	Independent director
Ma Li	Supervisors

Hualan Biological Engineering Headlines

No Headlines